| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.0076 | 0.9 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |